Mackay Shields LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,343	Closed	-$10.7M	–	609
2022 Q1	$10.7M	Sell	15,343 -458	-3%	-$290K	0.09%	213
2021 Q4	$9.98M	Sell	15,801 -221	-1%	-$136K	0.08%	232
2021 Q3	$9.7M	Sell	16,022 -463	-3%	-$287K	0.09%	218
2021 Q2	$9.21M	Sell	16,485 -10,843	-40%	-$5.49M	0.09%	224
2021 Q1	$12.9M	Sell	27,328 -20,643	-43%	-$10.1M	0.09%	228
2020 Q4	$23.2M	Buy	47,971 +1,276	+3%	+$689K	0.16%	143
2020 Q3	$26.1M	Buy	46,695 +2,851	+7%	+$1.73M	0.18%	113
2020 Q2	$27.3M	Buy	43,844 +10,010	+30%	+$5.68M	0.22%	101
2020 Q1	$16.5M	Buy	33,834 +15,164	+81%	+$6.25M	0.15%	161
2019 Q4	$7.01M	Sell	18,670 -2,892	-13%	-$973K	0.05%	399
2019 Q3	$5.98M	Sell	21,562 -6,878	-24%	-$2.04M	0.04%	447
2019 Q2	$8.9M	Sell	28,440 -10,112	-26%	-$3.37M	0.06%	367
2019 Q1	$15.8M	Buy	38,552 +17,480	+83%	+$7.2M	0.11%	219
2018 Q4	$7.87M	Buy	21,072 +8,713	+70%	+$3.19M	0.06%	361
2018 Q3	$4.99M	Sell	12,359 -160	-1%	-$60.9K	0.04%	447
2018 Q2	$4.32M	Sell	12,519 -20,050	-62%	-$6.27M	0.03%	518
2018 Q1	$11.2M	Buy	+32,569	New	+$11.3M	0.07%	328